Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics

Paolo Pozzilli, Tadej Battelino, Thomas Danne, Roman Hovorka, Przemyslawa Jarosz‐Chobot, Eric Renard

Open source

DOI
10.1002/dmrr.2653
Published
2015-06-22
Container
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dmrr.2653,
  title = {Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics},
  author = {Paolo Pozzilli and Tadej Battelino and Thomas Danne and Roman Hovorka and Przemyslawa Jarosz‐Chobot and Eric Renard},
  year = {2015},
  journal = {Diabetes/Metabolism Research and Reviews},
  doi = {10.1002/dmrr.2653},
  url = {https://doi.org/10.1002/dmrr.2653}
}

RIS

TY  - JOUR
TI  - Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
AU  - Paolo Pozzilli
AU  - Tadej Battelino
AU  - Thomas Danne
AU  - Roman Hovorka
AU  - Przemyslawa Jarosz‐Chobot
AU  - Eric Renard
PY  - 2015
JO  - Diabetes/Metabolism Research and Reviews
DO  - 10.1002/dmrr.2653
UR  - https://doi.org/10.1002/dmrr.2653
ER  - 

APA

Pozzilli, P., Battelino, T., Danne, T., Hovorka, R., Jarosz‐Chobot, P., & Renard, E. (2015). Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.2653

Source records